Olema Pharmaceuticals, Inc (OLMA)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Sean Bohen |
Employees: | 70 |
Web site: | olema.com |
780 BRANNAN STREET, SAN FRANCISCO, CA, 94103
(415) 651-3316
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Olema Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapies for women's cancers. OP-1250, an estrogen receptor antagonist and a selective ER degrader, is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
Please log in first to see chart